{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:16:30Z","timestamp":1771935390739,"version":"3.50.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"vor","delay-in-days":1384,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.repc.2015.03.005","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T09:09:52Z","timestamp":1436346592000},"page":"479-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Patologia cardiovascular associada ao v\u00edrus da imunodefici\u00eancia humana"],"prefix":"10.1016","volume":"34","author":[{"given":"Lu\u00edsa","family":"Amado Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana G.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2015.03.005_bib0005","unstructured":"UNAIDS. UNAIDS Report of the global AIDS epidemic 2013 [accessado a 27 de dezembro de 2013]. Dispon\u00edvel em: http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2013\/gr2013\/UNAIDS_Global_Report_2013_en.pdf"},{"key":"10.1016\/j.repc.2015.03.005_bib0010","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of Death in HIV\u20101\u2013Infected Patients Treated with Antiretroviral Therapy, 1996\u20102006: Collaborative Analysis of 13 HIV Cohort Studies","volume":"50","author":"Gill","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.repc.2015.03.005_bib0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.medmal.2008.03.006","article-title":"\u00c9tude de la pr\u00e9valence des cardiomyopathies au cours de l\u2019infection VIH: \u00e9tude prospective de 158 patients VIH","volume":"38","author":"El Hattaoui","year":"2008","journal-title":"Med Mal Infect."},{"key":"10.1016\/j.repc.2015.03.005_bib0020","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/0735-1097(88)90213-6","article-title":"Prevalent myocarditis at necropsy in acquired immunodeficiency syndrome","volume":"11","author":"Anderson","year":"1988","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.repc.2015.03.005_bib0025","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/ajem.2001.28323","article-title":"HIV\u2010associated cardiovascular complications: A new challenge for emergency physicians","volume":"19","author":"Barbaro","year":"2001","journal-title":"Am J Emerg Med."},{"key":"10.1016\/j.repc.2015.03.005_bib0030","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2011.09.074","article-title":"Update on myocarditis","volume":"59","author":"Kindermann","year":"2012","journal-title":"JACC"},{"key":"10.1016\/j.repc.2015.03.005_bib0035","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJM199810153391601","article-title":"Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV positive patients","volume":"339","author":"Barbaro","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2015.03.005_bib0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0167-5273(97)00321-5","article-title":"Heart involvement and HIV infection in African patients: determinants of survival","volume":"64","author":"Longo-Mbenza","year":"1998","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.repc.2015.03.005_bib0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00126334-200107010-00018","article-title":"Low prevalence of cardiac abnormalities in an HIV\u2010seropositive population on antiretroviral combination therapy","volume":"27","author":"Bijl","year":"2001","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1016\/j.repc.2015.03.005_bib0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/157016207779316288","article-title":"Prevalence of dilated cardiomyopathy in HIV\u2010infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda","volume":"5","author":"Twagirumukiza","year":"2007","journal-title":"Curr HIV Res."},{"key":"10.1016\/j.repc.2015.03.005_bib0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijcard.2007.10.057","article-title":"Diffuse\u2010regressive alterations and apoptosis of myocytes: Possible causes of myocardial dysfunction in HIV\u2010related cardiomyopathy","volume":"132","author":"Pozzan","year":"2009","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.repc.2015.03.005_bib0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/hrt.79.6.599","article-title":"Cardiac autoimmunity in HIV related heart muscle disease","volume":"79","author":"Currie","year":"1998","journal-title":"Heart."},{"key":"10.1016\/j.repc.2015.03.005_bib0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/labinvest.3780022","article-title":"Cardiac dysfunction occurs in the HIV\u20101 transgenic mouse treated with zidovudine","volume":"80","author":"Lewis","year":"2000","journal-title":"Lab Invest."},{"key":"10.1016\/j.repc.2015.03.005_bib0070","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/bmj.309.6969.1605","article-title":"Heart muscle disease related to HIV infection: Prognostic implications","volume":"309","author":"Currie","year":"1994","journal-title":"BMJ."},{"key":"10.1016\/j.repc.2015.03.005_bib0075","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00002030-200005050-00009","article-title":"Clinical course of cardiomyopathy in HIV\u2010infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor\u2010alpha and nitric oxide synthase","volume":"14","author":"Barbaro","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.repc.2015.03.005_bib0080","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0735-1097(00)01121-9","article-title":"Effect of beta\u2010blockers on circulating levels of inflammatory and anti\u2010inflammatory cytokines in patients with dilated cardiomyopathy","volume":"37","author":"Ohtsuka","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.repc.2015.03.005_bib0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1310\/hct1103-156","article-title":"Prevalence of cardiac diastolic dysfunction in HIV\u2010infected patients: results of the HIV\u2010HEART Study","volume":"11","author":"Reinsch","year":"2010","journal-title":"HIV Clin Trials."},{"key":"10.1016\/j.repc.2015.03.005_bib0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4330\/wjc.v2.i4.98","article-title":"Impaired diastolic function in na\u00efve untreated human immunodeficiency virus infected patients","volume":"2","author":"Oliviero","year":"2010","journal-title":"World J Cardiol."},{"key":"10.1016\/j.repc.2015.03.005_bib0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCHEARTFAILURE.109.854943","article-title":"Impact of HIV Infection on diastolic function and left ventricular mass","volume":"3","author":"Hsue","year":"2010","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.repc.2015.03.005_bib0100","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.repc.2013.12.006","article-title":"Impact of HIV infection on cardiac deformation","volume":"33","author":"Mendes","year":"2014","journal-title":"Rev Por Cardiol."},{"key":"10.1016\/j.repc.2015.03.005_bib0105","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.qai.0000243120.67529.78","article-title":"Incidence of risk factors for clinical presentation, and 1\u2010year outcomes of infective endocarditis in an urban HIV cohort","volume":"43","author":"Gebo","year":"2006","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1016\/j.repc.2015.03.005_bib0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/clinids\/22.1.40","article-title":"Infective endocarditis in injection drug users: importance of human immunodeficiency virus serostatus and degree of immunosuppression","volume":"22","author":"Pulvirenti","year":"1996","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.repc.2015.03.005_bib0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/jinf.2001.0812","article-title":"Infective endocarditis in patients with human immunodeficiency virus infection","volume":"42","author":"Cicalini","year":"2001","journal-title":"J Infect."},{"key":"10.1016\/j.repc.2015.03.005_bib0120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1471-2334-11-298","article-title":"Community\u2010associated methicillin\u2010resistant Staphylococcus aureus bacteremia and endocarditis among HIV patients: A cohort study","volume":"11","author":"Furuno","year":"2011","journal-title":"BMC Infect Dis."},{"key":"10.1016\/j.repc.2015.03.005_bib0125","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1161\/01.CIR.92.11.3229","article-title":"Pericardial effusion in AIDS. Incidence and survival","volume":"92","author":"Heidenreich","year":"1995","journal-title":"Circulation."},{"key":"10.1016\/j.repc.2015.03.005_bib0130","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/2047-783X-16-11-480","article-title":"Pericardial effusion of HIV\u2010infected patients \u2010 results of a prospective multicenter cohort study in the era of antiretroviral therapy","volume":"16","author":"Lind","year":"2011","journal-title":"Eur J Med Res."},{"key":"10.1016\/j.repc.2015.03.005_bib0135","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/archinte.160.5.602","article-title":"Cardiac manifestations of acquired immunodeficiency syndrome","volume":"160","author":"Rerkpattanapipat","year":"2000","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.repc.2015.03.005_bib0140","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1468-1293.2010.00829.x","article-title":"HIV and pulmonary arterial hypertension: a systematic review","volume":"11","author":"Janda","year":"2010","journal-title":"HIV Med."},{"key":"10.1016\/j.repc.2015.03.005_bib0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0025-6196(11)63616-1","article-title":"Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases","volume":"73","author":"Mesa","year":"1998","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.repc.2015.03.005_bib0150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.200704-541OC","article-title":"Prevalence of HIV\u2010related pulmonary arterial hypertension in the current antiretroviral therapy era","volume":"177","author":"Sitbon","year":"2008","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.repc.2015.03.005_bib0155","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0248-8663(01)00491-X","article-title":"Hypertension art\u00e9rielle pulmonaire primitive au cours de l\u2019infection par le virus de l\u2019immunod\u00e9ficience humaine \u00c9tude de neuf observations et revue de la litt\u00e9rature","volume":"22","author":"Houssine","year":"2001","journal-title":"Rev Med Interne."},{"issue":"suppl. 3","key":"10.1016\/j.repc.2015.03.005_bib0160","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/01.aids.0000327515.55041.da","article-title":"Mediators involved in HIV\u2010related pulmonary arterial hypertension","volume":"22","author":"Humbert","year":"2008","journal-title":"AIDS."},{"key":"10.1016\/j.repc.2015.03.005_bib0165","article-title":"Hipertensi\u00f3n arterial pulmonar en pacientes con infecci\u00f3n por el virus de la inmunodeficiencia humana: situaci\u00f3n actual","author":"Soto-Ab\u00e1nades","year":"2012","journal-title":"Enferm Infecc Microbiol Clin."},{"key":"10.1016\/j.repc.2015.03.005_bib0170","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Galie","year":"2009","journal-title":"Eur Heart J."},{"issue":"suppl 3","key":"10.1016\/j.repc.2015.03.005_bib0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/01.aids.0000327517.62665.ec","article-title":"HIV\u2010related pulmonary arterial hypertension: clinical presentation and management","volume":"22","author":"Sitbon","year":"2008","journal-title":"AIDS."},{"key":"10.1016\/j.repc.2015.03.005_bib0180","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1164\/rccm.200204-330OC","article-title":"Prognostic factors for survival in human immunodeficiency virus\u2010associated pulmonary arterial hypertension","volume":"167","author":"Nunes","year":"2003","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.repc.2015.03.005_bib0185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/QAD.0b013e328331c65e","article-title":"HIV\u2010associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era","volume":"24","author":"Degano","year":"2010","journal-title":"AIDS."},{"key":"10.1016\/j.repc.2015.03.005_bib0190","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1086\/383037","article-title":"Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy","volume":"38","author":"Zuber","year":"2004","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.repc.2015.03.005_bib0195","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4414\/smw.2001.09842","article-title":"Regression of HIV\u2010associated pulmonary arterial hypertension and long\u2010term survival during antiretroviral therapy","volume":"131","author":"Speich","year":"2001","journal-title":"Swiss Med Wkly."},{"key":"10.1016\/j.repc.2015.03.005_bib0200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0167-5273(00)00232-1","article-title":"Cardiac autonomic dysfunction in AIDS is not secondary to heart failure","volume":"74","author":"Neild","year":"2000","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.repc.2015.03.005_bib0205","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1475-097X.2007.00760.x","article-title":"Autonomic dysfunction in HIV patients on antiretroviral therapy: studies of heart rate variability","volume":"27","author":"Lebech","year":"2007","journal-title":"Clin Physiol Funct Imaging."},{"key":"10.1016\/j.repc.2015.03.005_bib0210","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7150\/ijms.4441","article-title":"Effects of antiretroviral therapy on autonomic function in early HIV infection: A preliminary report","volume":"9","author":"Chow","year":"2012","journal-title":"Int J Med Sci."},{"key":"10.1016\/j.repc.2015.03.005_bib0215","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","article-title":"Highly active antiretroral therapy and incidence of cancer in human immunodeficiency virus\u2010infected adults","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.repc.2015.03.005_bib0220","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/(SICI)1097-0215(19961211)68:6<754::AID-IJC11>3.0.CO;2-0","article-title":"Kaposi's sarcoma and non\u2010Hodgkin's lymphoma following the diagnosis of AIDS","volume":"68","author":"Biggar","year":"1996","journal-title":"Int J Cancer."},{"key":"10.1016\/j.repc.2015.03.005_bib0225","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/clc.4960200519","article-title":"Non\u2010Hodgkin's lymphoma of the heart in patients infected with human immunodeficiency virus","volume":"20","author":"Duong","year":"1997","journal-title":"Clin Cardiol."},{"key":"10.1016\/j.repc.2015.03.005_bib0230","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1378\/chest.90.2.243","article-title":"Malignant lymphoma of the heart in acquired immune deficiency syndrome","volume":"90","author":"Balasubramanyam","year":"1986","journal-title":"Chest."},{"key":"10.1016\/j.repc.2015.03.005_bib0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ancard.2013.03.004","article-title":"AIDS\u2010related primary cardiac lymphoma with right\u2010sided heart failure and high\u2010grade AV block: Insights from magnetic resonance imaging","volume":"63","author":"Llitjos","year":"2014","journal-title":"Ann Cardiol Angeiol (Paris)."},{"key":"10.1016\/j.repc.2015.03.005_bib0240","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jcp.54.4.275","article-title":"Vasculitides associated with HIV infection","volume":"54","author":"Chetty","year":"2001","journal-title":"J Clin Pathol."},{"issue":"Suppl 1","key":"10.1016\/j.repc.2015.03.005_bib0245","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/00002030-200304001-00011","article-title":"Kawasaki\u2010like syndromes other vasculitic syndromes in HIV\u2010infected patients","volume":"17","author":"Johnson","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.repc.2015.03.005_bib0250","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/520244","article-title":"Takayasu's arteritis in a human immunodeficiency virus\u2010infected adolescent","volume":"29","author":"Shingadia","year":"1999","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.repc.2015.03.005_bib0255","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/ejvs.2000.1169","article-title":"Clinical profile of HIV\u2010related aneurysms","volume":"20","author":"Nair","year":"2000","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"10.1016\/j.repc.2015.03.005_bib0260","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1078-5884(00)91195-X","article-title":"Occlusive arterial disease in HIV\u2010infected patients: a preliminary report","volume":"20","author":"Nair","year":"2000","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"10.1016\/j.repc.2015.03.005_bib0265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/QAD.0b013e3282f20a77","article-title":"Asymptomatic myocardial ischaemia in HIV\u2010infected adults","volume":"22","author":"Carr","year":"2008","journal-title":"AIDS."},{"key":"10.1016\/j.repc.2015.03.005_bib0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1874192401105010049","article-title":"HIV and HAART\u2010associated dyslipidemia","volume":"5","author":"Feeney","year":"2011","journal-title":"Open Cardiovasc Med J."},{"key":"10.1016\/j.repc.2015.03.005_bib0275","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/QAI.0b013e318042d5fe","article-title":"Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens","volume":"45","author":"Anastos","year":"2007","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1016\/j.repc.2015.03.005_bib0280","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.atherosclerosis.2006.12.022","article-title":"Both long\u2010term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis","volume":"196","author":"Lorenz","year":"2008","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.repc.2015.03.005_bib0285","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00126334-200308010-00012","article-title":"Coronary heart disease in HIV\u2010infected individuals","volume":"33","author":"Currier","year":"2003","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1016\/j.repc.2015.03.005_bib0290","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/HYPERTENSIONAHA.108.114660","article-title":"Aortic stiffness in untreated adult patients with human immunodeficiency virus infection","volume":"52","author":"Schillaci","year":"2008","journal-title":"Hypertension."},{"key":"10.1016\/j.repc.2015.03.005_bib0295","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/QAD.0b013e328300581d","article-title":"Low CD4+ T\u2010cell count as a major atherosclerosis risk factor in HIV\u2010infected women and men","volume":"22","author":"Kaplan","year":"2008","journal-title":"AIDS."},{"key":"10.1016\/j.repc.2015.03.005_bib0300","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.thromres.2011.11.022","article-title":"Endothelial and platelet function alterations in HIV\u2010infected patients","volume":"129","author":"Gresele","year":"2012","journal-title":"Thromb Res."},{"key":"10.1016\/j.repc.2015.03.005_bib0305","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00002030-200404300-00012","article-title":"Arterial stiffness and endothelial dysfunction in HIV\u2010infected children","volume":"18","author":"Bonnet","year":"2004","journal-title":"AIDS."},{"key":"10.1016\/j.repc.2015.03.005_bib0310","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1590\/S0066-782X2012005000110","article-title":"Terapia antirretroviral altamente eficaz para infec\u00e7\u00e3o pelo v\u00edrus da imunodefici\u00eancia humana aumenta a rigidez a\u00f3rtica","volume":"99","author":"Eira","year":"2012","journal-title":"Arq Bras Cardiol."},{"key":"10.1016\/j.repc.2015.03.005_bib0315","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/cid\/cir712","article-title":"The influence of antiretroviral therapy on the QTc interval in an African cohort","volume":"54","author":"Shavadia","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.repc.2015.03.005_bib0320","first-page":"1657","article-title":"QTc interval prolongation in patients with HIV and AIDS","volume":"97","author":"Mahmoud","year":"2005","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.repc.2015.03.005_bib0325","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-2261-12-124","article-title":"QTc interval prolongation in HIV\u2010infected patients: a case\u2013control study by 24\u2010hour Holter ECG recording","volume":"12","author":"Fiorentini","year":"2012","journal-title":"BMC Cardiovasc Disord."},{"key":"10.1016\/j.repc.2015.03.005_bib0330","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1310\/hct1004-261","article-title":"Prevalence and risk factors of prolonged QTc interval in HIV\u2010infected patients: Results of the HIV\u2010HEART Study","volume":"10","author":"Reinsch","year":"2009","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.repc.2015.03.005_bib0335","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/eurheartj\/ehi312","article-title":"Noncardiac QTc\u2010prolonging drugs and the risk of sudden cardiac death","volume":"26","author":"Strauss","year":"2005","journal-title":"Eur Heart J."},{"key":"10.1016\/j.repc.2015.03.005_bib0340","unstructured":"European AIDS Clinical Society. EACS Guidelines Version 7.1 \u2013 November 2014. English."},{"key":"10.1016\/j.repc.2015.03.005_bib0345","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jama.2014.8722","article-title":"Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society\u2013USA Panel","volume":"312","author":"Gunthard","year":"2014","journal-title":"JAMA."},{"key":"10.1016\/j.repc.2015.03.005_bib0350","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-M\u00f8ller","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.repc.2015.03.005_bib0355","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-M\u00f8ller","year":"2007","journal-title":"N Engl J Med."},{"key":"10.1016\/j.repc.2015.03.005_bib0360","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS Cohort Study","volume":"165","author":"Brown","year":"2005","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.repc.2015.03.005_bib0365","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/dc07-2013","article-title":"Incidence and risk factors for new\u2010onset diabetes in HIV\u2010infected patients: the Data Collection on Adverse Events of Anti\u2010HIV Drugs (D:A:D) study","volume":"31","author":"De Wit","year":"2008","journal-title":"Diabetes Care."},{"key":"10.1016\/j.repc.2015.03.005_bib0370","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1086\/518619","article-title":"Factors associated with the incidence of type 2 diabetes mellitus in HIV\u2010infected participants in the Swiss HIV Cohort Study","volume":"45","author":"Ledergerber","year":"2007","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.repc.2015.03.005_bib0375","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/hep.20289","article-title":"The risk of diabetes in HIV infected veterans in the pre\u2010 and post\u2010HAART era and the role of hepatitis C virus co\u2010infection","volume":"40","author":"Butt","year":"2004","journal-title":"Hepatology."},{"key":"10.1016\/j.repc.2015.03.005_bib0380","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.7448\/IAS.15.2.17426","article-title":"Predicting the short\u2010term risk of diabetes in HIV\u2010positive patients: the Data Collection on Adverse Events of Anti\u2010HIV Drugs (D:A:D) study","volume":"15","author":"Petoumenos","year":"2012","journal-title":"J Int AIDS Soc."},{"key":"10.1016\/j.repc.2015.03.005_bib0385","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/00002030-200309050-00022","article-title":"Stavudine or indinavir\u2010containing regimens are associated with an increased risk of diabetes mellitus in HIV\u2010infected individuals","volume":"17","author":"Brambilla","year":"2003","journal-title":"AIDS."},{"key":"10.1016\/j.repc.2015.03.005_bib0390","doi-asserted-by":"crossref","unstructured":"Diouf A, Cournil A, Ba\u2010Fall K et al. Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors. ISRN AIDS. 2012; volume 2012; Article ID 621565; doi:10.5402\/2012\/621565","DOI":"10.5402\/2012\/621565"},{"key":"10.1016\/j.repc.2015.03.005_bib0395","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.CIR.100.7.700","article-title":"Atherogenic dyslipidemia in HIV\u2010infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study","volume":"100","author":"Periard","year":"1999","journal-title":"Circulation."},{"key":"10.1016\/j.repc.2015.03.005_bib0400","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/135965350501000511","article-title":"Lipid profiles for antiretroviral\u2010naive patients starting PI\u2010 and NNRTI\u2010based therapy in the Swiss HIV cohort study","volume":"10","author":"Young","year":"2005","journal-title":"Antivir Ther."},{"key":"10.1016\/j.repc.2015.03.005_bib0405","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1371\/journal.pmed.0010019","article-title":"Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral\u2010therapy naive patients infected with HIV\u20101","volume":"1","author":"Van Leth","year":"2004","journal-title":"PLOS Med."},{"key":"10.1016\/j.repc.2015.03.005_bib0410","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa051871","article-title":"Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV","volume":"354","author":"Gallant","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.repc.2015.03.005_bib0415","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral\u2010naive patients: a 3\u2010year randomized trial","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA."},{"key":"10.1016\/j.repc.2015.03.005_bib0420","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1210\/jc.2002-020794","article-title":"Clinical review 153: lipodystrophy in human immunodeficiency virus\u2010infected patients","volume":"87","author":"Chen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"S1","key":"10.1016\/j.repc.2015.03.005_bib0425","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1097\/00002030-200304001-00017","article-title":"HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management","volume":"17","author":"Carr","year":"2003","journal-title":"AIDS."},{"key":"10.1016\/j.repc.2015.03.005_bib0430","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1468-1293.2005.00333.x","article-title":"Impact of highly active antiretroviral therapy on blood pressure in HIV\u2010infected patients. A prospective study in a cohort of naive patients","volume":"7","author":"Palacios","year":"2006","journal-title":"HIV Med."},{"key":"10.1016\/j.repc.2015.03.005_bib0435","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.aids.0000171410.76607.f8","article-title":"Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003","volume":"19","author":"Seaberg","year":"2005","journal-title":"AIDS."},{"key":"10.1016\/j.repc.2015.03.005_bib0440","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10096-003-1034-z","article-title":"Prevalence of hypertension in HIV\u2010positive patients on highly active retroviral therapy (HAART) compared with HAART\u2010naive and HIV\u2010negative controls: results from a Norwegian study of 721 patients","volume":"22","author":"Bergersen","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.repc.2015.03.005_bib0445","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/01.aids.0000222074.45372.00","article-title":"Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy","volume":"20","author":"Crane","year":"2006","journal-title":"AIDS."},{"key":"10.1016\/j.repc.2015.03.005_bib0450","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/518285","article-title":"Ischemic heart disease in HIV\u2010infected and HIV\u2010uninfected individuals: a population\u2010based cohort study","volume":"44","author":"Obel","year":"2007","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.repc.2015.03.005_bib0455","first-page":"749","article-title":"Complica\u00e7\u00f5es cardiovasculares da terapia anti\u2010retrov\u00edrica altamente activa. A prop\u00f3sito de um caso cl\u00ednico","volume":"28","author":"Cabanelas","year":"2009","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.repc.2015.03.005_bib0460","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1468-1293.2006.00400.x","article-title":"Prevalence of risk factors for cardiovascular disease in HIV\u2010infected patients over time: the Swiss HIV Cohort Study","volume":"7","author":"Glass","year":"2006","journal-title":"HIV Med."},{"key":"10.1016\/j.repc.2015.03.005_bib0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1468-1293.2003.00138.x","article-title":"Modelling the 3\u2010year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti\u2010HIV Drugs (DAD) study","volume":"4","author":"Law","year":"2003","journal-title":"HIV Med."},{"key":"10.1016\/j.repc.2015.03.005_bib0470","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","article-title":"Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection","volume":"348","author":"Bozzette","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.repc.2015.03.005_bib0475","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti\u2010 HIV drugs (D:A:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"J Infect Dis."},{"key":"10.1016\/j.repc.2015.03.005_bib0480","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/cid\/ciq244","article-title":"No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long\u2010term results from ACTG A5001\/ALLRT","volume":"52","author":"Ribaudo","year":"2011","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.repc.2015.03.005_bib0485","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/HJR.0b013e328336a150","article-title":"Predicting the risk of cardiovascular disease in HIV\u2010infected patients: the Data collection on Adverse Effects of Anti\u2010HIV Drugs Study","volume":"17","author":"Friis-M\u00f8ller","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil."},{"key":"10.1016\/j.repc.2015.03.005_bib0490","first-page":"801","article-title":"Determina\u00e7\u00e3o do consumo de sal numa amostra da popula\u00e7\u00e3o portuguesa adulta pela excre\u00e7\u00e3o urin\u00e1ria de s\u00f3dio. Sua rela\u00e7\u00e3o com rigidez arterial","volume":"25","author":"Pol\u00f3nia","year":"2006","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.repc.2015.03.005_bib0495","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.atherosclerosis.2008.08.017","article-title":"Cardiovascular prevention in HIV patients: results from a successful intervention program","volume":"204","author":"Lima","year":"2009","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.repc.2015.03.005_bib0500","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/01.aids.0000174458.86121.43","article-title":"Rosuvastatin for the treatment of hyperlipidaemia in HIV\u2010infected patients receiving protease inhibitors: a pilot study","volume":"19","author":"Calza","year":"2005","journal-title":"AIDS."}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255115001328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255115001328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:03:04Z","timestamp":1760108584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255115001328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":100,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0870255115001328"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2015.03.005","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patologia cardiovascular associada ao v\u00edrus da imunodefici\u00eancia humana","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2015.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}